Please login to the form below
Understanding personas for healthcare
In this article, Head of Insight Martine Leroy tackles the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some frequently asked questions about these and other tools used for improving customer engagement.
In recent years, there has been a big shift in how pharma
and healthcare companies approach the design and development of patient
services. Something we’ve talked about a lot at Blue Latitude Health is the move
toward customer-centricity and what that actually means in the healthcare
and pharma context. Out of those conversations has emerged a need for more
clarity around some of the tools used in the customer-centric
design process.
In this article, Head of Insight Martine Leroy tackles one of those tools: the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some frequently asked questions about these and other tools used for improving customer engagement.
Simply put, a persona is an individual representation of a group of customers and their behaviours, attitudes, and context. It’s a tool that gives life to the customer by illustrating their everyday activities, frustrations, pain points, and motivations. Driven by quantitative and qualitative data about actual customers, the persona is a valuable tool and point of reference used to keep the customer at the centre of the design process.
Pen portraits and customer segments are also tools that are used in the design process to improve customer engagement, but they are generated differently from a persona. A pen portrait is one level above the persona – it is broader, and is considered an overview of who the customer might be and what they might do. The pen portrait focuses on general customer lifestyle or on their role, related needs, and actions.
A customer segment is designed to support targeted communications and marketing. We do customer segmentation to identify and summarise groups of potential (or existing) customers, focusing on what drives their behaviour. In pharma, we tend to develop physician segments based on their attitudes and prescribing behaviours, and also increasingly develop segments for other healthcare professionals (HCPs). In each of those segments might exist 2-3 different personas, HCPs who exhibit similar prescribing behaviour but who are driven by different motivations.
![]()
In this article, Head of Insight Martine Leroy tackles one of those tools: the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some frequently asked questions about these and other tools used for improving customer engagement.
What is a persona, and how does it differ from a pen portrait or a segment?
First, let’s remember that personas, pen portraits and segments are all tools designed for a specific objective and that they need to be fit for that purpose. Additionally, the three tools are developed from the bottom up, which means they are grounded in customer-centric data and information.Simply put, a persona is an individual representation of a group of customers and their behaviours, attitudes, and context. It’s a tool that gives life to the customer by illustrating their everyday activities, frustrations, pain points, and motivations. Driven by quantitative and qualitative data about actual customers, the persona is a valuable tool and point of reference used to keep the customer at the centre of the design process.
Pen portraits and customer segments are also tools that are used in the design process to improve customer engagement, but they are generated differently from a persona. A pen portrait is one level above the persona – it is broader, and is considered an overview of who the customer might be and what they might do. The pen portrait focuses on general customer lifestyle or on their role, related needs, and actions.
A customer segment is designed to support targeted communications and marketing. We do customer segmentation to identify and summarise groups of potential (or existing) customers, focusing on what drives their behaviour. In pharma, we tend to develop physician segments based on their attitudes and prescribing behaviours, and also increasingly develop segments for other healthcare professionals (HCPs). In each of those segments might exist 2-3 different personas, HCPs who exhibit similar prescribing behaviour but who are driven by different motivations.
Download the full article from Blue Latitude Health
Company Details
Blue Latitude Health
+44 203 328 1840
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Three strategies for managing loss of exclusivity successfully
- Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
- What does the future hold for Medical Affairs?
- Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
- Unpacking rare diseases in the first edition of Delta magazine
- Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
